The pharmaceutical market in the United Kingdom is projected to grow from $28.8 billion in 2015 to about $43 billion by 2020 (a CAGR of 8.4%), according to research and consulting firm GlobalData.
The company’s latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK," states that the UK’s life sciences sector consists of just under 5,000 companies that develop, produce and market products and services in the pharmaceutical, medical device, and biotechnology markets.
Adam Dion, MSc, GlobalData’s Senior Industry Analyst, says the pharmaceutical sector is one of the most dynamic industries in the UK and is a major contributor to the country’s economy. Dion explains: “The pharmaceutical industry was the sixth largest contributor to the UK’s balance of trade, contributing $46.9 billion (£32.4 billion) to the economy in 2014, according to the Association of the British Pharmaceutical Industry.
“Research and development investment reached $5.9 billion (£4.2 billion) in 2013 in the UK, and the industry employed more than 68,000 staff, including 23,000 scientists and doctors,” he added.
For more information on GlobalData's report, click here.